Market Place
Sourcing Support
All News #Library
Janssen`s Imaavy Approved in Canada
05 Dec 2025 //
HEALTH CANADA
Centocor’s Biologics Stelara Receives Suppl Approval in US
27 Jun 2025 //
FDA
Centocor`s Biologic Simponi Receives Suppl Approval in US
18 Apr 2025 //
FDA
Centocor`s Biologic Stelara Receives Approval in US
01 Apr 2025 //
FDA
Centocor`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.
18 Mar 2024 //
FDA
Centocor`s Biologic Simponi (golimumab) Receives Approval in the U.S.
16 Nov 2023 //
FDA
Centocor`s Biologic Simponi (Golimumab) Receives Approval in the U.S.
30 Mar 2023 //
FDA
Centocor `s Remicade Receives Supplimental Approval in U.S
07 Oct 2021 //
FDA
Centocor`s Remicade (Infliximab) Receives Supplemental Approval in US
18 May 2020 //
FDA
Centocor`s STELARA (ustekinumab) Receives Supplemental Approval
09 Nov 2019 //
FDA
Centocor`s Reopro (Abciximab) Receives Supplemental Approval in US
09 Aug 2019 //
FDA
Centocor`s Selara (Ustekinumab) Receives Supplemental Approval In US
22 Feb 2018 //
FDA
Centocor’s Generic Infliximab Receives Supplemental Approval In US
26 Oct 2017 //
FDA
Janssen’s Darzalex Daratumumab Receives Supplemental Approval In US
19 Jun 2017 //
FDA
Janssen Biotech BLA Stelara Approved In US
23 Sep 2016 //
FDA
Janssen`s Darzalex (Daratumumab) approved in US for Multiple myeloma
19 Nov 2015 //
FDA
Janssen`s Invega Trinza (3- Month Paliperidone Palmitate) Approved in US For Schizophrenia
20 May 2015 //
JANSSEN
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.